Skip to content
Maui Sky – Lifestyle
Author:
Zealand Pharma
New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight management experience for people living with overweight and obesity
June 5, 2026
Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference
June 2, 2026
Zealand Pharma – Transactions related to share buy-back program (week 22, 2026)
June 1, 2026
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
May 29, 2026
Zealand Pharma to participate in the Jefferies Global Healthcare Conference
May 27, 2026
Zealand Pharma to Present Data at the American Diabetes Association’s 2026 Scientific Sessions
May 27, 2026
Zealand Pharma – Transactions related to share buy-back program (week 21, 2026)
May 26, 2026
Resolutions from Zealand Pharma’s Extraordinary General Meeting 2026
May 26, 2026
Zealand Pharma – Transactions related to share buy-back program (weeks 19-20, 2026)
May 14, 2026
Zealand Pharma Announces Financial Results for the First Three Months of 2026
May 7, 2026
1
2
3
Next Page
→